CaLu-05 - Human Lung Cancer Cell

Share
Print
Share
Print

Species: Human

Category: Cancer

Tissue of Origin: Lung

Cancer Type: Lung - Cancer

Description

CaLu-05 is a human lung adenocarcinoma cell line.

Source

This cell line was established in 1971 from lung metastasis in a person with lung adenocarcinoma

Lead Researcher/Research Laboratory

  • Jorgen Fogh, PhD, formerly at Sloan Kettering Institute, Memorial Sloan Kettering

Key References

PubMed=3518877; DOI=10.3109/07357908609038260 Fogh J.Human tumor lines for cancer research. Cancer Invest. 4:157-184(1986)PubMed=9636188; DOI=10.1073/pnas.95.13.7556 Kaplan D.H., Shankaran V., Dighe A.S., Stockert E., Aguet M., Old L.J., Schreiber R.D. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. U.S.A. 95:7556-7561(1998)

Licensing Information

This cell line may be licensed nonexclusively for research or commercial purposes.

For internal research purposes by a commercial entity: Utilize MSK’s Express License, attached here. In order to streamline and expedite the licensing of select MSK cell lines, the terms of this non-exclusive license are non-negotiable. Please note: This license is only available for select cell lines, including this one.

To proceed, please download this contract, fill in all relevant fields, and email a scanned version to TRMOTDRTM@mskcc.org. Once this license has been executed by MSK, you will receive a signed copy and invoice, and can then place your order with ATCC.

For licensing requests for a commercial purpose:  Contact MSK’s Tangible Materials team at TRMOTDRTM@mskcc.org.

For non-licensing requests from academic-research institutions: Contact Frances Weis-Garcia, PhD, Associate Laboratory Member/Head, Antibody & Bioresource Core Facility, MSK, 646-888-2354weisgarf@mskcc.org

Stage of Development

Ready to use